CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
Original article

Encoded secures $275m for Dravet syndrome gene therapy

Positive
AI Analysis

Summary

Encoded Therapeutics secured $275 million in funding to advance a Dravet syndrome gene therapy candidate into a pivotal trial in pediatric patients.

Clinical Trial Data

Phase

pivotal

Importance:7/10
Sentiment:
0.70
gene therapyDravet syndromepediatricfundingpivotal trial

Read the original article

Published by Pharmaceutical Technology on September 10, 2026 2:23 PM

Read Original